GI Partners will acquire a majority interest in Clinical Ink, Inc, a global clinical trial technology company. Existing Clinical Ink investor NovaQuest will continue to be a minority investor in the ...
SAN FRANCISCO, Aug. 26, 2020 /PRNewswire/ — GI Partners, a leading private investment firm, announced today it has completed the previously announced acquisition of Clinical Ink, Inc., a global ...
HORSHAM, Pa.--(BUSINESS WIRE)--Clinical Ink, a global clinical trial technology company, today announced its acquisition by GI Partners, a leading private equity investment firm. Existing investor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results